RCUS
Price
$15.91
Change
-$0.05 (-0.31%)
Updated
Dec 24 closing price
55 days until earnings call
THRD
Price
$10.32
Change
-$0.48 (-4.44%)
Updated
Dec 24 closing price
90 days until earnings call
Ad is loading...

RCUS vs THRD

Header iconRCUS vs THRD Comparison
Open Charts RCUS vs THRDBanner chart's image
Arcus Biosciences
Price$15.91
Change-$0.05 (-0.31%)
Volume$157.24K
CapitalizationN/A
Third Harmonic Bio
Price$10.32
Change-$0.48 (-4.44%)
Volume$93.28K
CapitalizationN/A
RCUS vs THRD Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. THRD commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Buy and THRD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 26, 2024
Stock price -- (RCUS: $15.91 vs. THRD: $10.32)
Brand notoriety: RCUS and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 20% vs. THRD: 43%
Market capitalization -- RCUS: $1.46B vs. THRD: $465M
RCUS [@Biotechnology] is valued at $1.46B. THRD’s [@Biotechnology] market capitalization is $465M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, both RCUS and THRD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 3 TA indicator(s) are bullish while THRD’s TA Score has 2 bullish TA indicator(s).

  • RCUS’s TA Score: 3 bullish, 7 bearish.
  • THRD’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, THRD is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а -1.06% price change this week, while THRD (@Biotechnology) price change was -9.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

RCUS is expected to report earnings on Feb 19, 2025.

THRD is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.46B) has a higher market cap than THRD($465M). THRD YTD gains are higher at: -5.925 vs. RCUS (-16.702). THRD has higher annual earnings (EBITDA): -52.79M vs. RCUS (-257M). RCUS has more cash in the bank: 1.09B vs. THRD (296M). THRD has less debt than RCUS: THRD (3.4M) vs RCUS (58M). RCUS has higher revenues than THRD: RCUS (263M) vs THRD (0).
RCUSTHRDRCUS / THRD
Capitalization1.46B465M313%
EBITDA-257M-52.79M487%
Gain YTD-16.702-5.925282%
P/E RatioN/AN/A-
Revenue263M0-
Total Cash1.09B296M368%
Total Debt58M3.4M1,704%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTHRD
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 17 days ago
90%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWVAX12.260.11
+0.91%
Hotchkis & Wiley Sm Cp Divers Val A
PEGCX20.470.18
+0.89%
PGIM Jennison Mid-Cap Growth C
VEVRX46.470.36
+0.78%
Victory Sycamore Established Value R6
ECOAX8.940.04
+0.45%
Ecofin Global Renewables Infras A
FHLKX10.350.03
+0.29%
Fidelity Health Savings K

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ACLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-0.31%
ACLX - RCUS
47%
Loosely correlated
+1.03%
OCUL - RCUS
46%
Loosely correlated
-2.69%
ALLO - RCUS
44%
Loosely correlated
+7.18%
PRME - RCUS
43%
Loosely correlated
-1.78%
DNLI - RCUS
43%
Loosely correlated
+0.67%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with PRME. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
-4.44%
PRME - THRD
42%
Loosely correlated
-1.78%
NVAX - THRD
42%
Loosely correlated
-1.50%
ALDX - THRD
40%
Loosely correlated
-0.73%
RVMD - THRD
38%
Loosely correlated
+1.05%
ABUS - THRD
38%
Loosely correlated
-0.31%
More